Abstrakt

Przypisy

• 1. An X., Guo X., Zhang X., Baines A.J., Debnath G., Moyo D., SalomaoM., Bhasin N., Johnson C., Discher D., Gratzer W.B., Mohandas N.: Conformationalstabilities of the structural repeats of erythroid spectrinand their functional implications. J. Biol. Chem., 2006; 281:10527-10532
  Google Scholar
• 2. Andrade J., Pearce S.T., Zhao H., Barroso M.: Interactions amongp22, glyceraldehyde-3 phosphate dehydrogenase and microtubules.Biochem. J., 2004; 384: 327-336
  Google Scholar
• 3. Antonelou M.H., Papassideri I.S., Karababa F.J., Stravopodis D.J., LoutradiA., Margaritis L.H.: Defective organization of the erythroid cell membranein a novel case of congenital anemia. Blood Cells Mol. Dis., 2003; 30: 43-54
  Google Scholar
• 4. Bober J., Kedzierska K., Safranow K., Kwiatkowska E., Jakubowska K.,Herdzik E., Dołegowska B., Domański L., Ciechanowski K.: Influence ofglucose in dialyzing fluid on purine concentrations in hemodialyzed patientswith chronic renal failure. Nephron. Clin. Pract., 2003; 95: c31-c36
  Google Scholar
• 5. Bober J., Kwiatkowska E., Kedzierska K., Olszewska M., DolegowskaB., Domanski L., Herdzik E., Ciechanowski K., Chlubek D.: Doesglucose present in the dialysate limit oxidative stress in patientsundergoing regular hemodialysis? Blood Purif., 2005; 23: 219-225
  Google Scholar
• 6. Bratosin D., Mazurier J., Tissier J.P., Estaquier J., Huart J.J., AmeisenJ.C., Aminoff D., Montreuil J.: Cellular and molecular mechanismsof senescent erythrocyte phagocytosis by macrophages. Areview. Biochimie, 1998; 80: 173-195
  Google Scholar
• 7. Celedón G., González G., Lissi E.A., Hidalgo G.: Free radical-inducedprotein degradation of erythrocyte membrane is influenced bythe localization of radical generation. IUBMB Life, 2001 51: 377-380
  Google Scholar
• 8. Chakrabarti A., Kelkar D.A., Chattopadhyay A.: Spectrin organizationand dynamics: new insights. Biosci Rep., 2006; 26: 369-386
  Google Scholar
• 9. Chattopadhyay A., Rawat S.S., Kelkar D.A., Ray S., Chakrabarti A.: Organizationand dynamics of tryptophan residues in erythroid spectrin:novel structural features of denatured spectrin revealed by the wavelength-selectivefluorescence approach. Protein Sci., 2003; 12: 2389-2403
  Google Scholar
• 10. Chiu D.T., Liu T.Z.: Free radical and oxidative damage in humanblood cells. J. Biomed. Sci., 1997; 4: 256-259
  Google Scholar
• 11. Cibulka R., Racek J.: Metabolic disorders in patients with chronickidney failure. J. Physiol. Res., 2007; 56: 697-705
  Google Scholar
• 12. Costa E., Rocha S., Rocha-Pereira P., Castro E., Miranda V., doSameiro Faria M., Loureiro A., Quintanilha A., Belo L., Santos-SilvaA.: Altered erythrocyte membrane protein composition in chronickidney disease stage 5 patients under haemodialysis and recombinanthuman erythropoietin therapy. Blood Purif., 2008; 26: 267-273 [13] Costa E., Rocha S., Rocha-Pereira P., Castro E., Miranda V., FariaM., Loureiro A., Quintanilha A., Belo L., Santos-Silva A.: Changes inred blood cells membrane protein composition during hemodialysisprocedure. Ren. Fail., 2008; 30: 971-975 [14] Delaunay J.: Molecular basis of red cell membrane disorders.Acta Haematol., 2002; 108: 210-218 15 Dodge J.T., Mitchell C., Hanahan D.J.: The preparation and chemicalcharacteristics of hemoglobin-free ghosts of human erythrocytes.Arch. Biochem. Biophys., 1963; 100: 119-130 16 Dolegowska B., Stepniewska J., Ciechanowski K., Safranow K., MilloB., Bober J., Chlubek D.: Does glucose in dialysis fluid protect erythrocytesin patients with chronic renal failure? Blood Purif., 2007; 25: 422-429 17 Gallagher P.G.: Red cell membrane disorders. Hematology ASHEducation Book, 2005; 1: 13-18 18 Harrison M.L., Rathinavelu P., Arese P., Geahlen R.L., Low P.S.:Role of band 3 tyrosine phosphorylation in the regulation of erythrocyteglycolysis. J. Biol. Chem., 1991; 266: 4106-4111 19 Ibrahim F.F., Ghannam M.M., Ali F.M.: Effect of dialysis on erythrocytemembrane of chronically hemodialyzed patients. Ren. Fail.,2002; 24: 779-790 20 Jollow D.J., McMillan D.C.: Oxidative stress, glucose-6-phosphatedehydrogenase and the red cell. Adv. Exp. Med. Biol., 2001; 500: 595-605 21 Kuypers F.A., Yuan J., Lewis R.A., Snyder L.M., Kiefer C.R., BunyaratvejA., Fucharoen S., Ma L., Styles L., de Jong K., Schrier S.L.:Membrane phospholipid asymmetry in human thalassemia. Blood,1998; 91: 3044-3051 22 Laemmli U.K.: Cleavage of structural proteins during the assemblyof the head of acteriophage T4. Nature, 1970; 227: 680-685 23 Liu S.C., Yi S.J., Mehta J.R., Nichols P.E., Ballas S.K., Yacono P.W.,Golan D.E., Palek J.: Red cell membrane remodeling in sickle cellanemia. Sequestration of membrane lipids and proteins in Heinzbodies. J. Clin. Invest., 1996; 97: 29-36 24 Low P.S., Rathinavelu P., Harrison M.L.: Regulation of glycolysisvia reversible enzyme binding to the membrane protein, band 3. J.Biol. Chem., 1993; 268: 14627-14631 25 Low P.S., Waugh S.M., Zinke K., Drenckhahn D.: The role of hemoglobindenaturation and band 3 clustering in red blood cell aging.Science, 1985; 227: 531-533 26 Mallozzi C., Di Stasi A.M., Minetti M.: Free radicals induce reversiblemembrane-cytoplasm translocation of glyceraldehyde-3-phosphatedehydrogenase in human erythrocytes. Arch. Biochem. Biophys.,1995; 321: 345-352 27 Margetis P., Antonelou M., Karababa F., Loutradi A., MargaritisL., Papassideri I.: Physiologically important secondary modificationsof red cell membrane in hereditary spherocytosis-evidence for invivo oxidation and lipid rafts protein variations. Blood Cells Mol.Dis., 2007; 38: 210-220 28 Mohandas N., An X.: New insights into function of red cell membraneproteins and their interaction with spectrin-based membraneskeleton. Transfus. Clin. Biol., 2006; 13: 29-30 29 Mohandas N., Gallagher P.G.: Red cell membrane: past, present,and future. Blood, 2008; 112: 3939-3947 30 Morrison M., Jackson C.W., Mueller T.J., Huang T., Dockter M.E.,Walker W.S., Singer J.A., Edwards H.H.: Does cell density correlatewith red cell age? Biomed. Biochim. Acta, 1983; 42: S107-S111 31 Neumann C.A., Krause D.S., Carman C.V., Das S., Dubey D.P.,Abraham J.L., Bronson R.T., Fujiwara Y., Orkin S.H., Van Etten R.A.:Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidantdefence and tumour suppression. Nature, 2003; 424: 561-565 32 Olszewska M., Wiatrow J., Bober J., Stachowska E., GołembiewskaE., Jakubowska K., Stańczyk-Dunaj M., Pietrzak-Nowacka M.: Oxidativestress modulates the organization of erythrocyte membranecytoskeleton. Postępy Hig. Med. Dośw., 2012; 66: 534-542 33 Pandolfi P.P., Sonati F., Rivi R., Mason P., Grosveld F., LuzzattoL.: Targeted disruption of the housekeeping gene encoding glucose6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentosesynthesis but essential for defense against oxidative stress. EMBOJ., 1995; 14: 5209-5215 34 Reliene R., Mariani M., Zanella A., Reinhart W.H., Ribeiro M.L.,del Giudice E.M., Perrotta S., Iolascon A., Eber S., Lutz H.U.: Splenectomyprolongs in vivo survival of erythrocytes differently inspectrin/ankyrin- and band 3-deficient hereditary spherocytosis.Blood, 2002; 100: 2208-2215 35 Rice-Evans C.A., Symons M., Diplock A.T.: Techniques In FreeRadical Research. Elsevier Sci. Techn., 1991 36 Richterich R.: Chemia kliniczna. PZWL Warszawa, 1971 37 Rocha S., Rebelo I., Costa E., Catarino C., Belo L., Castro E.M.,Cabeda J.M., Barbot J., Quintanilha A., Santos-Silva A.: Protein deficiencybalance as a predictor of clinical outcome in hereditaryspherocytosis. Eur. J. Haematol., 2005; 74: 374-380 38 Rogalski A.A., Steck T.L., Waseem A.: Association of glyceraldehyde-3-phosphatedehydrogenase with the plasma membrane ofthe intact human red blood cell. J. Biol. Chem. 1989; 264: 6438-6446 39 Rutkowski B., Zdrojewski Z., Górski J., Badzio T., Manitius A.: Theinfluence of uremic acidosis on carbohydrate and lipid metabolismin erythrocytes. Przegl. Lek. 1985; 42: 425-427 40 Snyder L.M., Fairbanks G., Trainor J., Fortier N.L., Jacobs J.B., LebL.: Properties and characterization of vesicles released by young andold human red cells. Br. J. Haematol., 1985; 59: 513-522 41 Stepniewska J., Dolegowska B., Ciechanowski K., KwiatkowskaE., Millo B., Chlubek D.: Erythrocyte antioxidant defense system inpatients with chronic renal failure according to the hemodialysisconditions. Arch. Med. Res., 2006; 37: 353-359 42 Tse W.T., Lux S.E.: Red blood cell membrane disorders. Br. J.Haematol., 1999; 104: 2-13 43 Turrini F., Arese P., Yuan J., Low P.S.: Clustering of integral membraneproteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis. J.Biol. Chem., 1991; 266: 23611-23617 44 Viljoen M.: Physical properties of the red blood cells in chronicrenal failure. Nephron, 1991; 59: 271-278 45 Wallas C.H.: Metabolic studies on red cells from patients withchronic renal disease on haemodialysis. Br. J. Haematol., 1974; 26: 71-78 46 Waugh S.M., Walder J.A., Low P.S.: Partial characterization of thecopolymerization reaction of erythrocyte membrane band 3 withhemichromes. Biochemistry, 1987; 26: 1777-1783 47 Zhang Z., Apse K., Pang J., Stanton R.C.: High glucose inhibitsglucose-6-phosphate dehydrogenase via cAMP in aortic endothelialcells. J. Biol. Chem., 2000; 275: 40042- 40047 48 Zinkham W.H., Houtchens R.A., Caughey W.S.: Relation betweenvariations in the phenotypic expression of an unstable hemoglobindisorder (hemoglobin Zurich) and carboxyhemoglobin levels. Am.J. Med., 1983; 74: 23-29
  Google Scholar

Pełna treść artykułu